Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes

During cardiac muscle development, most cardiomyocytes permanently withdraw from the cell cycle. Previously, by suppressive subtractive hybridization, we identified calcyclin‐binding protein/Siah‐interacting protein (CacyBP/SIP) as one of the candidates being upregulated in the hyperplastic to hypertrophic switch, suggesting an important role of CacyBP/SIP in cardiac development. To show the importance of CacyBP/SIP during myoblast differentiation, we report here that CacyBP/SIP is developmentally regulated in postnatal rat hearts. The overexpression of CacyBP/SIP promotes the differentiation and DNA synthesis of H9C2 cells and primary rat cardiomyocytes, as well as downregulates the expression of β‐catenin. Besides, CacyBP/SIP promotes the formation of myotubes and multinucleation upon differentiation. To investigate the cardioprotective role of CacyBP/SIP in cardiomyocytes, a hypoxia/reoxygenation model was employed. We found that CacyBP/SIP was upregulated during myocardial infarction (MI) and hypoxia/reoxygenation. As a conclusion, CacyBP/SIP may play a role in cardiomyogenic differentiation and possibly protection of cardiomyocytes during hypoxia/reoxygenation injury. J. Cell. Biochem. 98: 555–566, 2006. © 2006 Wiley‐Liss, Inc.

[1]  J. Kuźnicki,et al.  Molecular Cloning and Expression of a Mouse Brain cDNA Encoding a Novel Protein Target of Calcyclin , 1998, Journal of neurochemistry.

[2]  B. Padanilam,et al.  Induction of calcyclin after ischemic injury to rat kidney. , 1997, The American journal of physiology.

[3]  D. Srivastava,et al.  Molecular Pathways Controlling Heart Development , 1996, Science.

[4]  K. Nakayama,et al.  Impaired degradation of inhibitory subunit of NF-κB (IκB) and β-catenin as a result of targeted disruption of the β-TrCP1 gene , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Koh,et al.  Differential and dramatic changes of cyclin-dependent kinase activities in cardiomyocytes during the neonatal period. , 1997, Journal of molecular and cellular cardiology.

[6]  Jacek Kuznicki,et al.  Characterization of the Interaction of Calcyclin (S100A6) and Calcyclin-binding Protein* , 2000, The Journal of Biological Chemistry.

[7]  L. Kaczmarek,et al.  Altered expression of G1-specific genes in human malignant myeloid cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Albanese,et al.  The cyclin D 1 gene is a target of the b-catenin y LEF-1 pathway , 1999 .

[9]  K. Nakayama,et al.  Impaired degradation of inhibitory subunit of NF-kappa B (I kappa B) and beta-catenin as a result of targeted disruption of the beta-TrCP1 gene. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  L. Kaczmarek,et al.  Calcyclin (S100A6) Binding Protein (CacyBP) Is Highly Expressed in Brain Neurons , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[11]  J. Kuźnicki,et al.  Ca2+-dependent Translocation of the Calcyclin-binding Protein in Neurons and Neuroblastoma NB-2a Cells* , 2002, The Journal of Biological Chemistry.

[12]  K. Tang,et al.  Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro , 2003, Journal of cellular biochemistry.

[13]  P. Anversa,et al.  Ventricular myocytes are not terminally differentiated in the adult mammalian heart. , 1998, Circulation research.

[14]  E. Dejana,et al.  -Catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse , 2004 .

[15]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Cuppen,et al.  The Wnt/β-catenin pathway regulates cardiac valve formation , 2003, Nature.

[17]  F. Deist,et al.  SIAH-1 inhibits cell growth by altering the mitotic process , 1999, Oncogene.

[18]  F. Clubb,et al.  Formation of binucleated myocardial cells in the neonatal rat. An index for growth hypertrophy. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[19]  D. Zimmer,et al.  The S100 protein family: History, function, and expression , 1995, Brain Research Bulletin.

[20]  C. Liew,et al.  Role of the Adenomatous Polyposis Coli Gene Product in Human Cardiac Development and Disease* , 2000, The Journal of Biological Chemistry.

[21]  A. Gerdes,et al.  Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. , 1996, Journal of molecular and cellular cardiology.

[22]  J C Reed,et al.  Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. , 2001, Molecular cell.

[23]  S. Tsui,et al.  Differential gene expression of rat neonatal heart analyzed by suppression subtractive hybridization and expressed sequence tag sequencing , 2000, Journal of cellular biochemistry.

[24]  M. Kitagawa,et al.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication , 2000, The EMBO journal.

[25]  G. Buckberg,et al.  Cardiopulmonary dysfunction produced by reoxygenation of immature hypoxemic animals supported by cardiopulmonary bypass. Prevention by intravenous metabolic pretreatment. , 1993, The Journal of thoracic and cardiovascular surgery.